Dr. Niharika B. Mettu
Overview
My passion is the treatment of patients with gastrointestinal (GI) malignancies. I strive to take the very best care of my patients that I possibly can. Working with world-class colleagues and a multidisciplinary team, which includes radiation and surgical oncologists, makes this possible. I first became interested in oncology as a first-year medical student when I got to see tumors in my pathology class. I came to appreciate the beauty of the gastrointestinal tract while observing GI surgeries as a second-year medical student. My fascination with how cancers develop and how we may develop new therapies to treat cancer led me to pursue a PhD in molecular cancer biology. This training honed the critical thinking skills that I still use to this day, as I decide how to best treat my patients. The close relationships that oncologists have with patients and their families clinched my decision to pursue a career as a medical oncologist. During my fellowship training, I sought out subspecialty training in GI oncology. When I am not working, I enjoy spending time with my husband and four young children and running.
Dr. Mettu is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.
Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MEDICARE MAPD
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Mettu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Reidy is rated as an Elite provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is rated as an Elite provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma.
Duke Cancer Center
I decided to go to medical school during the early part of college and then never really looked back. I enjoyed every discipline while I was in medical school and had a difficult time selecting a specialty, until I did a rotation in Hematology/Oncology. After observing the relationships that oncologists develop with patients and their families, I knew that medical oncology was the right place for me. Getting to know my patients and their families and helping them achieve their goals, despite a cancer diagnosis, has become extremely important to me. I also enjoy working as part of a multidisciplinary team to make sure that patients get the most comprehensive care possible. When I am not working, I enjoy spending time with family, reading, and running. Dr. Uronis is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Gastroesophageal Junction Cancer, Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Pancreaticoduodenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Mettu isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Mettu isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Mettu isDistinguished. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction CancerDr. Mettu isDistinguished. Learn about Gastroesophageal Junction Cancer.
- Lynch SyndromeDr. Mettu isDistinguished. Learn about Lynch Syndrome.
- Pancreatic CancerDr. Mettu isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Ampullary CancerDr. Mettu isAdvanced. Learn about Ampullary Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)
- Pancreatic Ductal Adenocarcinoma
- PancreatoblastomaDr. Mettu isAdvanced. Learn about Pancreatoblastoma.
- Stomach CancerDr. Mettu isAdvanced. Learn about Stomach Cancer.
- Experienced
- Anal CancerDr. Mettu isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Mettu isExperienced. Learn about Appendix Cancer.
- Fibrolamellar CarcinomaDr. Mettu isExperienced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Mettu isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Mettu isExperienced. Learn about Gallbladder Cancer.
- Liver CancerDr. Mettu isExperienced. Learn about Liver Cancer.